nodes	percent_of_prediction	percent_of_DWPC	metapath
Sodium Tetradecyl Sulfate—PROC—bone marrow—ovarian cancer	0.0522	0.144	CbGeAlD
Sodium Tetradecyl Sulfate—PROS1—myometrium—ovarian cancer	0.045	0.124	CbGeAlD
Sodium Tetradecyl Sulfate—Orlistat—FASN—ovarian cancer	0.0413	1	CrCbGaD
Sodium Tetradecyl Sulfate—PROS1—Vinblastine—Vinorelbine—ovarian cancer	0.0362	1	CbGdCrCtD
Sodium Tetradecyl Sulfate—Extravasation—Carboplatin—ovarian cancer	0.0358	0.0775	CcSEcCtD
Sodium Tetradecyl Sulfate—PROS1—uterine cervix—ovarian cancer	0.035	0.0969	CbGeAlD
Sodium Tetradecyl Sulfate—PROS1—decidua—ovarian cancer	0.0333	0.0923	CbGeAlD
Sodium Tetradecyl Sulfate—PROS1—endometrium—ovarian cancer	0.0317	0.0876	CbGeAlD
Sodium Tetradecyl Sulfate—PROS1—uterus—ovarian cancer	0.0292	0.0807	CbGeAlD
Sodium Tetradecyl Sulfate—PROS1—female reproductive system—ovarian cancer	0.0262	0.0726	CbGeAlD
Sodium Tetradecyl Sulfate—Local reaction—Melphalan—ovarian cancer	0.0253	0.0548	CcSEcCtD
Sodium Tetradecyl Sulfate—PROS1—bone marrow—ovarian cancer	0.0248	0.0685	CbGeAlD
Sodium Tetradecyl Sulfate—PROS1—female gonad—ovarian cancer	0.0239	0.066	CbGeAlD
Sodium Tetradecyl Sulfate—PROS1—vagina—ovarian cancer	0.0237	0.0656	CbGeAlD
Sodium Tetradecyl Sulfate—Local reaction—Vinorelbine—ovarian cancer	0.0221	0.0479	CcSEcCtD
Sodium Tetradecyl Sulfate—PROS1—testis—ovarian cancer	0.0212	0.0586	CbGeAlD
Sodium Tetradecyl Sulfate—Extravasation—Topotecan—ovarian cancer	0.0164	0.0355	CcSEcCtD
Sodium Tetradecyl Sulfate—Extravasation—Melphalan—ovarian cancer	0.0161	0.0348	CcSEcCtD
Sodium Tetradecyl Sulfate—Necrosis—Vinorelbine—ovarian cancer	0.0156	0.0338	CcSEcCtD
Sodium Tetradecyl Sulfate—PROS1—lymph node—ovarian cancer	0.0153	0.0425	CbGeAlD
Sodium Tetradecyl Sulfate—Ulcer—Melphalan—ovarian cancer	0.0148	0.0321	CcSEcCtD
Sodium Tetradecyl Sulfate—Pulmonary embolism—Topotecan—ovarian cancer	0.0143	0.031	CcSEcCtD
Sodium Tetradecyl Sulfate—Extravasation—Vinorelbine—ovarian cancer	0.014	0.0304	CcSEcCtD
Sodium Tetradecyl Sulfate—Pulmonary embolism—Vinorelbine—ovarian cancer	0.0122	0.0265	CcSEcCtD
Sodium Tetradecyl Sulfate—Necrosis—Paclitaxel—ovarian cancer	0.0105	0.0227	CcSEcCtD
Sodium Tetradecyl Sulfate—Vomiting—Altretamine—ovarian cancer	0.0103	0.0222	CcSEcCtD
Sodium Tetradecyl Sulfate—Nausea—Altretamine—ovarian cancer	0.00958	0.0207	CcSEcCtD
Sodium Tetradecyl Sulfate—Pain—Carboplatin—ovarian cancer	0.00953	0.0206	CcSEcCtD
Sodium Tetradecyl Sulfate—Extravasation—Paclitaxel—ovarian cancer	0.00943	0.0204	CcSEcCtD
Sodium Tetradecyl Sulfate—Necrosis—Docetaxel—ovarian cancer	0.00889	0.0192	CcSEcCtD
Sodium Tetradecyl Sulfate—Local reaction—Epirubicin—ovarian cancer	0.0085	0.0184	CcSEcCtD
Sodium Tetradecyl Sulfate—Pulmonary embolism—Paclitaxel—ovarian cancer	0.00823	0.0178	CcSEcCtD
Sodium Tetradecyl Sulfate—Extravasation—Docetaxel—ovarian cancer	0.008	0.0173	CcSEcCtD
Sodium Tetradecyl Sulfate—Local reaction—Doxorubicin—ovarian cancer	0.00786	0.017	CcSEcCtD
Sodium Tetradecyl Sulfate—Pulmonary embolism—Docetaxel—ovarian cancer	0.00698	0.0151	CcSEcCtD
Sodium Tetradecyl Sulfate—Necrosis—Epirubicin—ovarian cancer	0.00599	0.013	CcSEcCtD
Sodium Tetradecyl Sulfate—Necrosis—Doxorubicin—ovarian cancer	0.00555	0.012	CcSEcCtD
Sodium Tetradecyl Sulfate—PROC—Post-translational protein modification—MUC16—ovarian cancer	0.0055	0.0554	CbGpPWpGaD
Sodium Tetradecyl Sulfate—Extravasation—Epirubicin—ovarian cancer	0.00539	0.0117	CcSEcCtD
Sodium Tetradecyl Sulfate—Anaphylactic shock—Topotecan—ovarian cancer	0.0051	0.0111	CcSEcCtD
Sodium Tetradecyl Sulfate—Anaphylactic shock—Melphalan—ovarian cancer	0.005	0.0108	CcSEcCtD
Sodium Tetradecyl Sulfate—Extravasation—Doxorubicin—ovarian cancer	0.00499	0.0108	CcSEcCtD
Sodium Tetradecyl Sulfate—Ulcer—Epirubicin—ovarian cancer	0.00497	0.0108	CcSEcCtD
Sodium Tetradecyl Sulfate—Pain—Chlorambucil—ovarian cancer	0.0049	0.0106	CcSEcCtD
Sodium Tetradecyl Sulfate—PROS1—Post-translational protein modification—MUC16—ovarian cancer	0.00487	0.049	CbGpPWpGaD
Sodium Tetradecyl Sulfate—Pulmonary embolism—Epirubicin—ovarian cancer	0.00471	0.0102	CcSEcCtD
Sodium Tetradecyl Sulfate—Ulcer—Doxorubicin—ovarian cancer	0.0046	0.00997	CcSEcCtD
Sodium Tetradecyl Sulfate—Urticaria—Chlorambucil—ovarian cancer	0.00455	0.00986	CcSEcCtD
Sodium Tetradecyl Sulfate—PROS1—Platelet degranulation—SPARC—ovarian cancer	0.00442	0.0445	CbGpPWpGaD
Sodium Tetradecyl Sulfate—Anaphylactic shock—Vinorelbine—ovarian cancer	0.00437	0.00945	CcSEcCtD
Sodium Tetradecyl Sulfate—Pain—Topotecan—ovarian cancer	0.00436	0.00945	CcSEcCtD
Sodium Tetradecyl Sulfate—Pulmonary embolism—Doxorubicin—ovarian cancer	0.00435	0.00943	CcSEcCtD
Sodium Tetradecyl Sulfate—Pain—Melphalan—ovarian cancer	0.00427	0.00925	CcSEcCtD
Sodium Tetradecyl Sulfate—Hypersensitivity—Chlorambucil—ovarian cancer	0.00422	0.00915	CcSEcCtD
Sodium Tetradecyl Sulfate—PROS1—Response to elevated platelet cytosolic Ca2+—SPARC—ovarian cancer	0.00421	0.0424	CbGpPWpGaD
Sodium Tetradecyl Sulfate—Urticaria—Topotecan—ovarian cancer	0.00405	0.00878	CcSEcCtD
Sodium Tetradecyl Sulfate—Urticaria—Melphalan—ovarian cancer	0.00397	0.0086	CcSEcCtD
Sodium Tetradecyl Sulfate—Hypersensitivity—Topotecan—ovarian cancer	0.00376	0.00814	CcSEcCtD
Sodium Tetradecyl Sulfate—Pain—Vinorelbine—ovarian cancer	0.00373	0.00808	CcSEcCtD
Sodium Tetradecyl Sulfate—Hypersensitivity—Melphalan—ovarian cancer	0.00368	0.00797	CcSEcCtD
Sodium Tetradecyl Sulfate—Vomiting—Chlorambucil—ovarian cancer	0.00364	0.00789	CcSEcCtD
Sodium Tetradecyl Sulfate—Urticaria—Vinorelbine—ovarian cancer	0.00347	0.00751	CcSEcCtD
Sodium Tetradecyl Sulfate—Nausea—Chlorambucil—ovarian cancer	0.0034	0.00737	CcSEcCtD
Sodium Tetradecyl Sulfate—Vomiting—Topotecan—ovarian cancer	0.00324	0.00703	CcSEcCtD
Sodium Tetradecyl Sulfate—Hypersensitivity—Vinorelbine—ovarian cancer	0.00322	0.00697	CcSEcCtD
Sodium Tetradecyl Sulfate—PROS1—Platelet degranulation—SOD1—ovarian cancer	0.00321	0.0323	CbGpPWpGaD
Sodium Tetradecyl Sulfate—Headache—Topotecan—ovarian cancer	0.0032	0.00692	CcSEcCtD
Sodium Tetradecyl Sulfate—Vomiting—Melphalan—ovarian cancer	0.00318	0.00688	CcSEcCtD
Sodium Tetradecyl Sulfate—PROS1—Response to elevated platelet cytosolic Ca2+—SOD1—ovarian cancer	0.00306	0.0308	CbGpPWpGaD
Sodium Tetradecyl Sulfate—Nausea—Topotecan—ovarian cancer	0.00303	0.00656	CcSEcCtD
Sodium Tetradecyl Sulfate—Nausea—Melphalan—ovarian cancer	0.00297	0.00643	CcSEcCtD
Sodium Tetradecyl Sulfate—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00294	0.00636	CcSEcCtD
Sodium Tetradecyl Sulfate—Vomiting—Vinorelbine—ovarian cancer	0.00278	0.00601	CcSEcCtD
Sodium Tetradecyl Sulfate—Headache—Vinorelbine—ovarian cancer	0.00273	0.00592	CcSEcCtD
Sodium Tetradecyl Sulfate—PROC—Metabolism of proteins—MUC16—ovarian cancer	0.00261	0.0263	CbGpPWpGaD
Sodium Tetradecyl Sulfate—Nausea—Vinorelbine—ovarian cancer	0.00259	0.00562	CcSEcCtD
Sodium Tetradecyl Sulfate—Pain—Paclitaxel—ovarian cancer	0.00251	0.00544	CcSEcCtD
Sodium Tetradecyl Sulfate—Anaphylactic shock—Docetaxel—ovarian cancer	0.00249	0.00539	CcSEcCtD
Sodium Tetradecyl Sulfate—Urticaria—Paclitaxel—ovarian cancer	0.00233	0.00505	CcSEcCtD
Sodium Tetradecyl Sulfate—PROS1—Metabolism of proteins—MUC16—ovarian cancer	0.00231	0.0233	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROC—Cell surface interactions at the vascular wall—CAV1—ovarian cancer	0.00224	0.0225	CbGpPWpGaD
Sodium Tetradecyl Sulfate—Hypersensitivity—Paclitaxel—ovarian cancer	0.00216	0.00469	CcSEcCtD
Sodium Tetradecyl Sulfate—PROC—Hemostasis—RAD51C—ovarian cancer	0.00214	0.0215	CbGpPWpGaD
Sodium Tetradecyl Sulfate—Pain—Docetaxel—ovarian cancer	0.00213	0.00461	CcSEcCtD
Sodium Tetradecyl Sulfate—PROS1—Cell surface interactions at the vascular wall—CAV1—ovarian cancer	0.00198	0.0199	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Platelet activation, signaling and aggregation—SPARC—ovarian cancer	0.00196	0.0197	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Hemostasis—RAD51C—ovarian cancer	0.00189	0.019	CbGpPWpGaD
Sodium Tetradecyl Sulfate—Vomiting—Paclitaxel—ovarian cancer	0.00187	0.00404	CcSEcCtD
Sodium Tetradecyl Sulfate—Headache—Paclitaxel—ovarian cancer	0.00184	0.00398	CcSEcCtD
Sodium Tetradecyl Sulfate—Hypersensitivity—Docetaxel—ovarian cancer	0.00183	0.00397	CcSEcCtD
Sodium Tetradecyl Sulfate—Nausea—Paclitaxel—ovarian cancer	0.00174	0.00378	CcSEcCtD
Sodium Tetradecyl Sulfate—PROC—Metabolism of proteins—INHA—ovarian cancer	0.00168	0.0169	CbGpPWpGaD
Sodium Tetradecyl Sulfate—Anaphylactic shock—Epirubicin—ovarian cancer	0.00168	0.00364	CcSEcCtD
Sodium Tetradecyl Sulfate—Vomiting—Docetaxel—ovarian cancer	0.00158	0.00343	CcSEcCtD
Sodium Tetradecyl Sulfate—PROC—Cell surface interactions at the vascular wall—PIK3CB—ovarian cancer	0.00156	0.0157	CbGpPWpGaD
Sodium Tetradecyl Sulfate—Headache—Docetaxel—ovarian cancer	0.00156	0.00338	CcSEcCtD
Sodium Tetradecyl Sulfate—Anaphylactic shock—Doxorubicin—ovarian cancer	0.00155	0.00336	CcSEcCtD
Sodium Tetradecyl Sulfate—PROS1—Metabolism of proteins—INHA—ovarian cancer	0.00149	0.015	CbGpPWpGaD
Sodium Tetradecyl Sulfate—Nausea—Docetaxel—ovarian cancer	0.00148	0.0032	CcSEcCtD
Sodium Tetradecyl Sulfate—Pain—Epirubicin—ovarian cancer	0.00144	0.00311	CcSEcCtD
Sodium Tetradecyl Sulfate—PROS1—Platelet activation, signaling and aggregation—SOD1—ovarian cancer	0.00142	0.0143	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Cell surface interactions at the vascular wall—PIK3CB—ovarian cancer	0.00138	0.0139	CbGpPWpGaD
Sodium Tetradecyl Sulfate—Urticaria—Epirubicin—ovarian cancer	0.00133	0.00289	CcSEcCtD
Sodium Tetradecyl Sulfate—Pain—Doxorubicin—ovarian cancer	0.00133	0.00288	CcSEcCtD
Sodium Tetradecyl Sulfate—PROS1—Platelet degranulation—VEGFA—ovarian cancer	0.00128	0.0129	CbGpPWpGaD
Sodium Tetradecyl Sulfate—Hypersensitivity—Epirubicin—ovarian cancer	0.00124	0.00268	CcSEcCtD
Sodium Tetradecyl Sulfate—Urticaria—Doxorubicin—ovarian cancer	0.00123	0.00267	CcSEcCtD
Sodium Tetradecyl Sulfate—PROS1—Response to elevated platelet cytosolic Ca2+—VEGFA—ovarian cancer	0.00122	0.0123	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROC—Cell surface interactions at the vascular wall—NRAS—ovarian cancer	0.0012	0.0121	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROC—Metabolism of proteins—TUBB3—ovarian cancer	0.00119	0.0119	CbGpPWpGaD
Sodium Tetradecyl Sulfate—Hypersensitivity—Doxorubicin—ovarian cancer	0.00114	0.00248	CcSEcCtD
Sodium Tetradecyl Sulfate—PROC—Hemostasis—SPARC—ovarian cancer	0.00114	0.0115	CbGpPWpGaD
Sodium Tetradecyl Sulfate—Vomiting—Epirubicin—ovarian cancer	0.00107	0.00231	CcSEcCtD
Sodium Tetradecyl Sulfate—PROS1—Cell surface interactions at the vascular wall—NRAS—ovarian cancer	0.00107	0.0107	CbGpPWpGaD
Sodium Tetradecyl Sulfate—Headache—Epirubicin—ovarian cancer	0.00105	0.00228	CcSEcCtD
Sodium Tetradecyl Sulfate—PROS1—Metabolism of proteins—TUBB3—ovarian cancer	0.00105	0.0106	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROC—Cell surface interactions at the vascular wall—KRAS—ovarian cancer	0.00104	0.0104	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Hemostasis—SPARC—ovarian cancer	0.00101	0.0102	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROC—Metabolism of proteins—ATF3—ovarian cancer	0.001	0.0101	CbGpPWpGaD
Sodium Tetradecyl Sulfate—Nausea—Epirubicin—ovarian cancer	0.000997	0.00216	CcSEcCtD
Sodium Tetradecyl Sulfate—Vomiting—Doxorubicin—ovarian cancer	0.000988	0.00214	CcSEcCtD
Sodium Tetradecyl Sulfate—Headache—Doxorubicin—ovarian cancer	0.000973	0.00211	CcSEcCtD
Sodium Tetradecyl Sulfate—PROC—Cell surface interactions at the vascular wall—PIK3CA—ovarian cancer	0.000952	0.00958	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Platelet activation, signaling and aggregation—PIK3CG—ovarian cancer	0.000949	0.00955	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Innate Immune System—IKBKG—ovarian cancer	0.000931	0.00937	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Innate Immune System—EREG—ovarian cancer	0.000931	0.00937	CbGpPWpGaD
Sodium Tetradecyl Sulfate—Nausea—Doxorubicin—ovarian cancer	0.000923	0.002	CcSEcCtD
Sodium Tetradecyl Sulfate—PROS1—Cell surface interactions at the vascular wall—KRAS—ovarian cancer	0.000917	0.00923	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Metabolism of proteins—ATF3—ovarian cancer	0.000886	0.00891	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROC—Cell surface interactions at the vascular wall—HRAS—ovarian cancer	0.000881	0.00886	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Cell surface interactions at the vascular wall—PIK3CA—ovarian cancer	0.000843	0.00848	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Platelet activation, signaling and aggregation—PIK3CD—ovarian cancer	0.000834	0.00839	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROC—Hemostasis—SOD1—ovarian cancer	0.00083	0.00835	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROC—Hemostasis—PPP2R1A—ovarian cancer	0.000826	0.00831	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Cell surface interactions at the vascular wall—HRAS—ovarian cancer	0.00078	0.00784	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Hemostasis—SOD1—ovarian cancer	0.000734	0.00739	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Hemostasis—PPP2R1A—ovarian cancer	0.000731	0.00735	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Platelet activation, signaling and aggregation—PIK3CB—ovarian cancer	0.000727	0.00732	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Immune System—PVRL2—ovarian cancer	0.000724	0.00729	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Platelet activation, signaling and aggregation—IL2—ovarian cancer	0.000668	0.00672	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Innate Immune System—PPP2R1A—ovarian cancer	0.000658	0.00662	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Immune System—PARK2—ovarian cancer	0.000618	0.00622	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROC—Hemostasis—CAV1—ovarian cancer	0.000607	0.00611	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Platelet activation, signaling and aggregation—VEGFA—ovarian cancer	0.000568	0.00571	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROC—Hemostasis—PIK3CG—ovarian cancer	0.000553	0.00556	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Immune System—EREG—ovarian cancer	0.000542	0.00546	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Immune System—IKBKG—ovarian cancer	0.000542	0.00546	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Hemostasis—CAV1—ovarian cancer	0.000537	0.0054	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Platelet activation, signaling and aggregation—MAPK3—ovarian cancer	0.000537	0.0054	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Immune System—SKP2—ovarian cancer	0.00053	0.00533	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Platelet activation, signaling and aggregation—MAPK1—ovarian cancer	0.000511	0.00514	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Hemostasis—PIK3CG—ovarian cancer	0.000489	0.00492	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROC—Hemostasis—PIK3CD—ovarian cancer	0.000486	0.00489	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Innate Immune System—TLR4—ovarian cancer	0.000478	0.00481	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Innate Immune System—IL6ST—ovarian cancer	0.000458	0.00461	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Platelet activation, signaling and aggregation—PIK3CA—ovarian cancer	0.000443	0.00446	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Hemostasis—PIK3CD—ovarian cancer	0.00043	0.00433	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROC—Hemostasis—PIK3CB—ovarian cancer	0.000424	0.00426	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROC—Hemostasis—IL2—ovarian cancer	0.000389	0.00391	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Innate Immune System—PIK3CD—ovarian cancer	0.000387	0.0039	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROC—Metabolism of proteins—MMP2—ovarian cancer	0.000385	0.00388	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Immune System—PPP2R1A—ovarian cancer	0.000383	0.00386	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Hemostasis—PIK3CB—ovarian cancer	0.000375	0.00377	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Platelet activation, signaling and aggregation—AKT1—ovarian cancer	0.000362	0.00364	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Hemostasis—IL2—ovarian cancer	0.000344	0.00346	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Innate Immune System—ERBB2—ovarian cancer	0.000342	0.00344	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Immune System—CD8A—ovarian cancer	0.000342	0.00344	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Metabolism of proteins—MMP2—ovarian cancer	0.000341	0.00343	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Innate Immune System—MTOR—ovarian cancer	0.000337	0.0034	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Innate Immune System—PIK3CB—ovarian cancer	0.000337	0.0034	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROC—Hemostasis—VEGFA—ovarian cancer	0.000331	0.00333	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROC—Hemostasis—NRAS—ovarian cancer	0.000326	0.00329	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROC—Metabolism of proteins—CXCL8—ovarian cancer	0.00032	0.00322	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Innate Immune System—CDKN1B—ovarian cancer	0.000317	0.00319	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROC—Hemostasis—MAPK3—ovarian cancer	0.000313	0.00315	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Innate Immune System—CTNNB1—ovarian cancer	0.000299	0.00301	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROC—Hemostasis—MAPK1—ovarian cancer	0.000298	0.00299	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROC—Metabolism of proteins—CTNNB1—ovarian cancer	0.000295	0.00297	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Hemostasis—VEGFA—ovarian cancer	0.000293	0.00294	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Innate Immune System—PTEN—ovarian cancer	0.000292	0.00293	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Hemostasis—NRAS—ovarian cancer	0.000289	0.00291	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Metabolism of proteins—CXCL8—ovarian cancer	0.000283	0.00285	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROC—Hemostasis—KRAS—ovarian cancer	0.000281	0.00283	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Immune System—TLR4—ovarian cancer	0.000278	0.0028	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Hemostasis—MAPK3—ovarian cancer	0.000277	0.00278	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Immune System—IL6ST—ovarian cancer	0.000267	0.00269	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Hemostasis—MAPK1—ovarian cancer	0.000263	0.00265	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Metabolism of proteins—CTNNB1—ovarian cancer	0.000261	0.00263	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Innate Immune System—NRAS—ovarian cancer	0.00026	0.00262	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROC—Hemostasis—PIK3CA—ovarian cancer	0.000258	0.0026	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROC—Hemostasis—TP53—ovarian cancer	0.00025	0.00251	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Innate Immune System—MAPK3—ovarian cancer	0.000249	0.00251	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Hemostasis—KRAS—ovarian cancer	0.000249	0.0025	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROC—Hemostasis—HRAS—ovarian cancer	0.000239	0.0024	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Innate Immune System—MAPK1—ovarian cancer	0.000237	0.00239	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Innate Immune System—EGFR—ovarian cancer	0.000237	0.00238	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Immune System—CDH1—ovarian cancer	0.000236	0.00238	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Hemostasis—PIK3CA—ovarian cancer	0.000228	0.0023	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Immune System—PIK3CD—ovarian cancer	0.000225	0.00227	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Innate Immune System—KRAS—ovarian cancer	0.000224	0.00225	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Hemostasis—TP53—ovarian cancer	0.000221	0.00222	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Hemostasis—HRAS—ovarian cancer	0.000211	0.00213	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROC—Hemostasis—AKT1—ovarian cancer	0.000211	0.00212	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Innate Immune System—PIK3CA—ovarian cancer	0.000206	0.00207	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Immune System—ERBB2—ovarian cancer	0.000199	0.002	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Immune System—PIK3CB—ovarian cancer	0.000197	0.00198	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Immune System—MTOR—ovarian cancer	0.000197	0.00198	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Innate Immune System—HRAS—ovarian cancer	0.00019	0.00191	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Hemostasis—AKT1—ovarian cancer	0.000187	0.00188	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Immune System—CDKN1B—ovarian cancer	0.000184	0.00186	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Innate Immune System—IL6—ovarian cancer	0.000182	0.00183	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Immune System—IL2—ovarian cancer	0.00018	0.00182	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Immune System—CTNNB1—ovarian cancer	0.000174	0.00175	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Immune System—PTEN—ovarian cancer	0.00017	0.00171	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Innate Immune System—AKT1—ovarian cancer	0.000168	0.00169	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Immune System—STAT3—ovarian cancer	0.000152	0.00153	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Immune System—NRAS—ovarian cancer	0.000152	0.00152	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Immune System—MAPK3—ovarian cancer	0.000145	0.00146	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Immune System—MAPK1—ovarian cancer	0.000138	0.00139	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Immune System—EGFR—ovarian cancer	0.000138	0.00139	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Immune System—KRAS—ovarian cancer	0.00013	0.00131	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Immune System—PIK3CA—ovarian cancer	0.00012	0.00121	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Immune System—HRAS—ovarian cancer	0.000111	0.00112	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Immune System—IL6—ovarian cancer	0.000106	0.00107	CbGpPWpGaD
Sodium Tetradecyl Sulfate—PROS1—Immune System—AKT1—ovarian cancer	9.79e-05	0.000985	CbGpPWpGaD
